We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
BALAXI.NSE

Price
67.76
Stock movement up
+1.01 (1.51%)
Company name
BALAXI PHARMACEUTICALS LIMITED
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Biotechnology
Market cap
3.45B
Ent value
3.56B
Price/Sales
1.35
Price/Book
1.60
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
9.69
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-42.12%
3 year return
-3.81%
5 year return
30.37%
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

BALAXI.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E9.69
Price to OCF358.57
Price to FCF358.57
Price to EBITDA25.50
EV to EBITDA26.33

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales1.35
Price to Book1.60
EV to Sales1.39

FINANCIALS

Per share

Per share data
Current share count50.91M
EPS (TTM)6.45
FCF per share (TTM)0.17

Income statement

Income statement data
Revenue (TTM)2.56B
Gross profit (TTM)1.12B
Operating income (TTM)363.88M
Net income (TTM)355.97M
EPS (TTM)6.45
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)43.84%
Operating margin (TTM)14.22%
Profit margin (TTM)13.91%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash608.67M
Net receivables812.61M
Total current assets2.39B
Goodwill262.25M
Intangible assets0.00
Property, plant and equipment0.00
Total assets2.88B
Accounts payable311.79M
Short/Current long term debt321.02M
Total current liabilities693.24M
Total liabilities720.97M
Shareholder's equity2.16B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)9.62M
Capital expenditures (TTM)0.00
Free cash flow (TTM)9.62M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity16.49%
Return on Assets12.36%
Return on Invested Capital14.46%
Cash Return on Invested Capital0.39%

STOCK INFORMATION

Stock chart

Stock price data
Open69.45
Daily high69.45
Daily low66.75
Daily Volume94K
All-time high208.03
1y analyst estimate-
Beta0.59
EPS (TTM)6.45
Dividend per share-
Ex-div date1 Jul 2022
Next earnings date-

Downside potential

Downside potential data
BALAXI.NSES&P500
Current price drop from All-time high-67.43%-12.89%
Highest price drop-75.41%-56.47%
Date of highest drop3 Mar 20259 Mar 2009
Avg drop from high-43.89%-11.07%
Avg time to new high22 days12 days
Max time to new high1117 days1805 days
COMPANY DETAILS
BALAXI.NSE (BALAXI PHARMACEUTICALS LIMITED) company logo
Marketcap
3.45B
Marketcap category
Mid-cap
Description
Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in Africa, the Caribbean Islands, and Latin America. The company offers pharmaceutical products across various therapeutic areas that mainly treats antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpastes. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. Balaxi Pharmaceuticals Limited was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.
Employees
0
Website
https://balaxipharma.in
Investor relations
-
SEC filings
BALAXI.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved